Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novartis
Woman and Man Max 99 years
Novartis Consumer Health
Update Il y a 4 ans
Clinical study to evaluate the efficacy and safety of diclofenac potassium 25 mg tablets in subjects with acute joint pain Klinische Prüfung zur Bewertung der Wirksamkeit und Sicherheit von Diclofenac-Kalium 25 mg Tabletten bei Probanden mit akuten Gelenkschmerzen
To evaluate the efficacy of diclofenac potassium 25 mg tablet taken 3 times a day compared with placebo in subjects with acute ankle sprains under ‘in-use’ conditions, in particular with regard to pai...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma B.V
Update Il y a 4 ans
Angiotensin II receptor blockers in patients with systemic right ventricle
The primary objective of this study is to determine whether Angiotensin II Receptor Blockers (valsartan) improve the functional (contractile, electrophysiologic) performance of the right ventricle in ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Pharma GmbH
Update Il y a 4 ans
An open-label clinical trial that evaluates the lung clearance index in cystic fibrosis patients ≥ 6 years of age, chronically infected with Pseudomonas aeruginosa
To assess the change of LCI after 4 weeks following onset of study drug inhalation versus Baseline
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
A randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of six months treatment with the tyrosine kinase inhibitor of STI571 for the treatment of pulmonary arterial hypertension
• To assess the safety and tolerability of oral STI571 compared with placebo in patients with pulmonary arterial hypertension. • To evaluate efficacy of oral STI571 as measured by improvement in 6-min...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Study of efficacy and safety of QAW039 in patients with severe asthma inadequately controlled with standard of care asthma treatment
In patients with severe asthma and high eosinophil counts (≥250 cells/μl) receiving SoC asthma therapy, to demonstrate the efficacy (as measured by rate of moderate-to-severe asthma exacerbations) of ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novartis Pharma AG
Update Il y a 4 ans
Study of safety, tolerability and preliminary efficacy of multiple intra-articular LNA043 injections in patients with articular cartilage lesions
• To assess the efficacy of multiple i.a. injections of LNA043 in regenerating the articular cartilage tissue • To assess safety and local tolerability of multiple i.a. injections of LNA043
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
Novartis Pharma
Update Il y a 4 ans
Étude CLXS196X2101 : étude de phase 1 non-randomisée visant à évaluer la sécurité d’emploi, la tolérance, la pharmacocinétique, la pharmacodynamique et l’efficacité du LXS196 en monothérapie et en association au HDM201 chez des patients ayant un mélanome uvéal métastatique. [essai clos aux inclusions]
Le mélanome uvéal est le cancer de l’oeil le plus fréquent chez l’adulte, mais il reste une maladie rare. Dans 20 à 50% des cas, ce cancer forme des métastases, souvent dans le foie. La tumeur primair...
Country
France
organs
Mélanomes oculaires
Specialty
Thérapies Ciblées
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
To demonstrate comparable efficacy as measured by the composite efficacy failure of tBPAR, graft loss or death with EVR in combination with rTAC compared to standard exposure TAC, at 12 months post-tr...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
To assess the progression-free survival (PFS) in patients who receive everolimus as second-line treatment for metastatic renal cell carcinoma
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Novartis Pharma Services AG
Update Il y a 4 ans
An exploratory study of the effects of Imatinib on allergic inflammation following out of allergy season repeated nasal allergen challenge in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen – an exploratory study of c-kit inhibition in allergic respiratory diseases
To assess the effects of Imatinib on allergic inflammation following repeated nasal allergen challenge (NAC) in subjects with seasonal allergic rhinitis sensitive to Timothy grass pollen – in particul...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
4
5
6
7
8
9
10
11
12
13
Next